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Abstract 
Endocrinopathic laminitis is frequently associated with hyperinsulinaemia but 
the role of glucose in the pathogenesis of the disease has not been fully investigated. 
This study aimed to determine the endogenous insulin response to a quantity of 
glucose equivalent to that administered during a laminitis-inducing, euglycaemic, 
hyperinsulinaemic clamp, over 48 h in insulin-sensitive Standardbred racehorses. In 
addition, the study investigated whether glucose infusion, in the absence of exogenous 
insulin administration, would result in the development of clinical and 
histopathological evidence of laminitis. Glucose (50% dextrose) was infused 
intravenously at a rate of 0.68 mL/kg/h for 48 h in treated horses (n = 4) and control 
horses (n = 3) received a balanced electrolyte solution (0.68 mL/kg/h).  
 
Lamellar histology was examined at the conclusion of the experiment. Horses 
in the treatment group were insulin sensitive (M value 0.039 ± 0.0012 mmol/kg/min 
and M-to-I ratio (x 100) 0.014 ± 0.002) as determined by an approximated 
hyperglycaemic clamp. Treated horses developed glycosuria, hyperglycaemia (10.7 ± 
0.78 mmol/L) and hyperinsulinaemia (208 ± 26.1 µIU/mL), whereas control horses 
did not. None of the horses became lame as a consequence of the experiment but all 
of the treated horses developed histopathological evidence of laminitis in at least one 
foot. Combined with earlier studies, the results showed that laminitis may be induced 
by either insulin alone or a combination of insulin and glucose, but that it is unlikely 
to be due to a glucose overload mechanism. Based on the histopathological data, the 
potential threshold for insulin toxicity (i.e. laminitis) in horses may be at or below a 
serum concentration of  ~200 µIU/mL. 
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Introduction 
Endocrinopathic laminitis is a disease affecting the lamellar region of the 
horse’s foot which arises secondary to hormonal dysfunction. Equine Cushing’s 
disease, equine metabolic syndrome and excessive consumption of carbohydrate-rich 
pasture, have all been repeatedly implicated as predisposing factors for the 
development of lamellar failure (McGowan, 2010). Research has further defined 
endocrinopathic and pasture-associated laminitis as diseases primarily associated with 
elevated serum insulin concentrations (Hess et al., 2005; McGowan et al., 2004; 
Treiber et al., 2006a).  
 
Although hyperinsulinaemia has been linked with the development of both 
naturally-occurring (Treiber et al., 2006b) and experimental (Asplin et al., 2007) 
forms of the disease, the mechanism by which an increase in circulating insulin can 
negatively impact on the lamellar region remains contentious. Previously, it has been 
demonstrated in horses that serum insulin concentrations > 1000 µIU/mL induce 
laminitis within 48 h (de Laat et al., 2010). However, the exogenous administration of 
insulin during a euglycaemic, hyperinsulinaemic clamp (EHC) necessitates the 
concurrent infusion of large amounts of glucose (DeFronzo et al., 1979). Although the 
subjects of a prolonged EHC remain euglycaemic at all times (de Laat et al., 2010), 
the effect of the infused glucose on lamellar tissues is unclear. Furthermore, pasture-
associated laminitis is linked to hyperinsulinaemia and the consumption of pastures 
rich in non-structural carbohydrate (Geor, 2009).  
 
Hyperglycaemia damages sensitive tissues, such as the kidney, in diabetic 
humans (Nishikawa et al., 2007). However, horses rarely develop type 2 diabetes, so 
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the consequences of hyperglycaemia and excessive glucose metabolism have received 
minimal attention in this species. The feedback relationship between insulin and 
glucose also means that determining the impact of one of these substances (in the 
absence of the other) is difficult to achieve in vivo. Moreover, the degree of 
hyperinsulinaemia associated with naturally-occurring endocrinopathic laminitis 
varies considerably between individuals, even those grazing the same pasture (Bailey 
et al., 2007; Carter et al., 2009), which makes the prediction of disease onset 
challenging. However, ponies with equine Cushing’s disease, with a serum insulin 
concentration > 188 µIU/mL, are at an increased risk of laminitis (McGowan et al., 
2004), which could suggest a primary role for insulin.  
 
In the current study, we sought to investigate the endogenous insulin response 
to a prolonged glucose infusion (48 h). We infused a quantity of glucose equivalent to 
that administered during our previous prolonged EHCs (~ 0.32 g/kg/h) in insulin-
sensitive, Standardbred horses (de Laat et al., 2010). We aimed to determine whether 
an increase in serum insulin concentration would occur in response to the glucose 
infusion and, if so, whether the resultant endogenous insulin concentrations would be 
as high as those recorded during an EHC (> 1000 µIU/mL). Our second objective was 
to determine whether the quantity of glucose administered during the EHC, and the 
accompanying endogenous insulin response, would result in clinical and 
histopathological evidence of laminitis. Our hypothesis was that endogenous 
hyperinsulinaemia of a lower magnitude than recorded during an EHC would develop 
secondary to a persistent glucose infusion over 48 h, and that this would not be 
sufficient to induce clinical or histopathological evidence of laminitis. 
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Materials and methods 
The experimental protocol was approved by the Animal Ethics Committee of 
the University of Queensland (SVS/108/09/RIRDC) which ensured compliance with 
the Animal Welfare Act of Queensland (2001) and the Australian Code of Practice for 
the Care and Use of Animals for Scientific Purposes (7th edition 2004). All horses 
were monitored by a registered veterinarian. 
 
Subjects 
Eight male, recently retired, Standardbred racehorses (417 ± 16 kg BW; 6.3 ± 
0.74 years) were used. They were in moderate body condition (4.3/9; Henneke et al., 
1983) and clinically normal on physical examination. Clinical and radiographic foot 
examination excluded horses with abnormalities associated with laminitis from the 
study. Heart rate, respiratory rate and rectal temperature were monitored daily prior to 
the study, and at 4 h intervals throughout the infusion period. All horses were subject 
to a pre and post-treatment lameness examination. Routine haematological and 
biochemical analyses were performed on blood samples (20 mL) drawn from all 
horses at the beginning and end of the study.  
 
Urinalysis was performed at 8 h intervals during the infusion period to semi-
quantitatively assess for glycosuria (Combur-9, Roche). The urine dipsticks were 
validated for equine urine against the hexokinase method using an automated clinical 
chemistry analyser (ρc = 0.99). All horses wore an equine nappy (Equisan) to facilitate 
urine collection.  
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Both forelimbs of all horses were fitted with pedometers, placed proximal to 
the carpus to determine if increased limb movement occurred secondary to shifting 
bodyweight, as a potential indicator of foot pain in treated horses. The horses were 
allocated at random to either a treatment or control group.  
 
The experiment was conducted as controlled replicates within 2 weeks. Horses 
were housed at the research facility for 1 week prior to the study and were fed 
medium quality lucerne chaff and hay. Ad libitum access to water and the same food 
were provided throughout the study period.  
  
Prolonged glucose infusion 
Extended-use, IV catheters (MilaCath) were aseptically placed and sutured 
into both jugular veins of all horses. The infusion was administered into the right 
catheter while the left was used for blood collection.  
 
Horses in the treatment group were administered a continuous infusion of 
glucose (50% dextrose, Baxter) over 48 h at a rate of 0.68 mL/kg/h. The rate was 
calculated from the quantity of glucose infused during previous EHCs (48 h) which 
resulted in clinical laminitis (de Laat et al., 2010). The glucose infusion rate was 
reduced in 10% increments if the blood glucose concentration exceeded 15 mmol/L, 
in order to avoid potential complications of marked hyperglycaemia. Control horses 
received a balanced electrolyte solution (Hartmanns, Baxter) at 0.68 mL/kg/h for 48 h.  
 
Blood samples (10 mL) were drawn for the measurement of blood glucose and 
serum insulin concentration at the following time-points: 0 h, 15 min, 30 min, 1 h, 90 
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min, 100 min, 110 min, 2 h, then hourly until 6 h, once at 8 h, then every 4 h to 48 h. 
Blood glucose concentration was determined immediately on fresh whole blood using 
a handheld glucometer (Accucheck, Roche) that was calibrated against the hexokinase 
method, for these horses, using an automated clinical chemistry analyser (Lin’s ρc = 
0.95). The remaining blood was placed in plain Vacutainers, allowed to clot (30 min) 
and centrifuged at 3000 g for 10 min. Aliquots of serum (1 mL) were stored at -80 ºC 
until analysed. Serum insulin concentrations were measured using  radioimmunoassay 
(Coat-a-count, Siemens) previously validated for use in horses (McGowan et al., 
2008). Samples from treated horses, from the 3 h time-point onwards, were diluted 
1:5 with insulin-free serum.  
 
Determination of insulin sensitivity 
Data from the initial 2 h of the infusion period was used as an approximated 
hyperglycaemic clamp (HC), to determine each treated horse’s tissue sensitivity to 
endogenous insulin in accordance with De Fronzo et al., (1979). The HC technique 
induces hyperglycaemia (6.9 mmol/L above normal), for a period of 120 min, which 
suppressed basal hepatic glucose production and facilitates assessment of the 
sensitivity of the pancreatic beta cells to glucose. Glucose metabolism is calculated 
during the steady state period (90 – 120 min) when blood glucose concentrations are 
stable (10.9 to 13.3 mmol/L).  
 
Although the infusion rate was not manipulated in the present study, a steady 
state period occurred and allowed insulin sensitivity values to be approximated for 
each treated horse. Thus, blood glucose and serum insulin concentrations taken during 
the steady state period ( 3 x 10 min) were used to calculate the amount of glucose 
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metabolised (M) and insulin sensitivity (M-to-I ratio), with allowances for urinary 
glucose loss and a space correction, using standard protocols (Rijnen and van der 
Kolk, 2003).  
 
Lamellar histopathology 
At the conclusion of the experiment the horses were humanely euthanased and 
necropsied. All four feet were immediately disarticulated at the metacarpo-phalangeal 
joint and cut into sagittal sections with a band saw. Lamellar tissue (5 mm x 5 mm) 
was dissected from the mid-dorsal region of each hoof with a scalpel, trimmed, rinsed 
and placed in 10% neutral buffered formalin for 24 h.  
 
Following fixation, lamellar samples were processed routinely for histology 
and stained with haematoxylin and eosin (H & E) and periodic acid Schiff (PAS). 
Prepared sections were coded, randomised and examined independently via light 
microscopy (Olympus BX-50), by two authors (CCP and MAD) who were blinded to 
treatment type. Each foot was examined at 100, 200 and 400x magnification, with a 
minimum of 30 microscopic fields and eight primary epidermal lamellae (PELs) 
examined at each magnification. The lamellar histopathology was graded using the 
following scale: 0, negative; 1, secondary epidermal lamellar (SEL) lengthening and 
narrowing, nuclear disorientation, prominent nucleoli, loss of uniform basal cell 
architecture and apoptosis; 2, as above plus increased mitosis and dermal 
polymorphonucleocytes (PMNs); 3, marked cellular and structural changes with 
basement membrane dysadhesion and loss.  
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Histometric measurements of SEL length (SELL) and width (SELW) were 
made in the axial (tip) and abaxial (base) halves of eight PEL from both forefeet by 
one of the authors (MAD), who was blinded to the treatment group, according to a 
previously validated protocol (de Laat et al., 2011). 
 
Statistical analysis 
All data were normally distributed (Shapiro-Wilk test; P > 0.05). Blood 
glucose and serum insulin concentrations were compared within (paired) and between 
(unpaired) groups with a t test. Pedometer readings from both forelimbs of each horse 
were totalled and compared between groups using a Welch t test. The presence or 
absence of lamellar histopathology was assessed as an outcome using Fisher’s exact 
probability test. Histometric measurements from each forefoot were averaged to 
obtain a single value for each horse and compared between groups using a Welch t 
test. All data are presented as means ± se and statistical significance was accepted at P 
< 0.05. Statistical analyses were performed using R, version 7.2.7. 
 
Results 
Subjects  
Lameness was not detected in any horse. Routine blood haematology and 
biochemistry results did not differ between treatment and control groups either before 
or after the study. Demeanour, appetite and heart and respiratory rates did not change 
throughout the experiment. Rectal temperature was unchanged in seven of the horses 
however one control horse was withdrawn from the experiment with a transient fever. 
This resulted in the final replicate consisting of one control and two treated horses, 
and a sample size of seven.  
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Urinalysis results were unremarkable prior to the experiment. However, all of 
the treated horses developed mild glycosuria within 8 h of glucose infusion and this 
continued to increase over the 48 h period (Fig. 1). Glycosuria was not detected in any 
control horse. Pedometer readings did not differ between groups (control; 7.1 ± 2.1 
steps/min and treatment; 5.5 ± 1.4 steps/min). 
 
Prolonged glucose infusion 
Glucose infusion was well tolerated by all of the treated horses and a reduction 
(10%) in infusion rate was only required in one horse between 14 h and 16 h. Basal 
blood glucose concentration did not differ between control (5.1 ± 0.13 mmol/L) and 
treated horses (5.7 ± 0.43 mmol/L) but blood glucose concentration (10.7 ± 0.78 
mmol/L) increased (P < 0.05) above the baseline value in the treated horses during 
glucose infusion (15 min – 48 h; Fig. 2). The control group maintained basal blood 
glucose concentrations during the infusion (Fig. 2).  
 
Basal serum insulin concentration was similar for treated (7.84 ± 0.29 µIU/mL) 
and control (8 ± 0.58 µIU/mL) horses and did not increase in the control group 
throughout the infusion (10.6 ± 1.36 µIU/mL). In contrast, serum insulin 
concentrations increased (P < 0.05) above basal levels during the glucose infusion in 
the treated group (24 h – 48 h; 208 ± 26.1 µIU/mL). A gradual increase in serum 
insulin concentration commenced within 15 min of the start of the infusion and was 
significantly elevated (121 ± 30 µIU/mL) above basal levels 4 h after the start of the 
experiment, reaching a peak concentration (268 ± 87 µIU/mL) by 32 h (Fig. 3). After 
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this there was no further increase in glucose and insulin concentration although 
glycosuria continued to increase up to 48 h (Fig. 1). 
 
Determination of insulin sensitivity 
During the steady state period (Fig. 2 inset) blood glucose and serum insulin 
concentrations for the treated horses were 12.5 ± 1.1 mmol/L and 41.7 ± 5.16 µIU/mL, 
respectively. The amount of glucose metabolised (M) during the steady state period 
for the treated horses was 0.039 ± 0.0012 mmol/kg/min and the M-to-I ratio (x 100) 
was 0.014 ± 0.002. 
 
Lamellar histopathology 
All four feet from control horses were normal (Table 1; Fig. 4a). In contrast, 
the treated horses developed histopathological evidence of laminitis in at least one 
foot (P < 0.05). The severity of lamellar histopathology varied among the treated 
horses with one horse sustaining lamellar pathology in one front foot only, compared 
to other horses with lamellar pathology in both front or all four, feet (Table 1).  
 
Lesions in the treatment group included lengthening and tapering of the SELs 
(Fig. 4c), compared to control horses (Fig. 5). SELs at both the axial and abaxial ends 
of the PELs were narrower (P < 0.05) in treated horses (Fig. 5). Secondary dermal 
lamellae (SDLs) were frequently obliterated, resulting in confluence of SEL basal 
cells near the PEL axis (Fig. 4b). Cellular changes included rounded epidermal basal 
cell nuclei with prominent nucleoli, loss of uniform basal and parabasal cell 
architecture and increased evidence of mitotic figures (Table 1) and apoptosis (Fig. 
4d). The basement membrane at the tips of the SELs was adjacent to the basal cell 
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layer but appeared irregular (Fig. 4b). Increased dermal presence of extravasated 
PMNs was seen around the axial tips of the PELs (Fig. 4d) in forefoot sections from 
three treated horses, compared to none in the control horses (Table 1).  
 
Discussion  
Our study has shown the endogenous insulin response of the equine pancreas 
to a prolonged glucose infusion in healthy, insulin-sensitive horses. It also 
demonstrated that hyperglycaemia and moderate hyperinsulinaemia can produce 
lamellar pathology consistent with laminitis in insulin-sensitive horses within 48 h. 
The results suggest that hyperinsulinaemic horses and ponies may have subclinical, 
endocrinopathic lamellar pathology that may progress to laminitis in the field. 
Considering that the quantity of glucose infused in this study was equivalent to the 
quantity that was administered during a laminitis-inducing EHC (de Laat et al., 2010), 
it appears unlikely that endocrinopathic laminitis is due to glucose overload alone. 
These results support the theory that endocrinopathic laminitis may arise secondary to 
hyperinsulinaemia in combination with an increased glucose load or 
hyperinsulinaemia alone. 
 
The EHC technique has been criticised for the excessively high serum insulin 
concentrations attained, and there is little doubt that the model represents an 
exaggerated form of the naturally-occurring disease, with laminitis occurring within a 
48 h period (de Laat et al., 2010). The current study has demonstrated that much 
lower (5-fold) serum insulin concentrations than those attained during the EHC are 
also capable of initiating lamellar damage, albeit less severe. This suggests that the 
severity of lamellar damage is closely linked with the magnitude of hyperinsulinaemia 
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and the time-frame over which it occurs, which can vary significantly between 
individuals. Insulin-resistant horses and ponies would be expected to produce a more 
exaggerated insulin response to carbohydrate ingestion and hyperglycaemia, and 
would therefore presumably be at risk of more severe lamellar injury than the insulin-
sensitive horses used here.  
 
An important aspect was to study the effects of hyperglycaemia and 
hyperinsulinaemia without the involvement of gastrointestinal variables, helping to 
make the study distinct from carbohydrate-overload laminitis. By administering the 
glucose intravenously (IV) we sought to mimic the glucose infusion component of the 
EHC, thereby developing a comparable technique, and we were also able to bypass 
the gastrointestinal tract. Carbohydrate-overload models of laminitis (and the 
naturally-occurring form of the disease that they seek to emulate) are associated with 
inappropriate hindgut fermentation and the systemic release of toxic factors that may 
initiate the syndrome (Garner et al., 1975). Insulin-induced laminitis is not associated 
with any clinical evidence of gastrointestinal involvement (Asplin et al., 2007; de Laat 
et al., 2010) and also appears to be a less inflammatory process than alimentary forms 
(de Laat et al., 2011).  
 
By administering the glucose IV we were able to approximate an HC. Several 
tests for the determination of insulin and glucose metabolism have been adapted for 
use in the horse (Firshman and Valberg, 2007) and have improved our ability to 
diagnose insulin resistance in this species. While basal glucose and insulin 
concentrations and ratios are used most frequently in a clinical setting, more invasive 
tests, such as clamps, have been used to more accurately determine insulin sensitivity 
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in ponies and horses (Pratt et al., 2006; Rijnen and van der Kolk, 2003). In particular, 
the HC suppresses endogenous hepatic glucose production, which facilitates 
determination of the sensitivity of the pancreatic beta cells to glucose, and tissue 
sensitivity to endogenously produced insulin (DeFronzo et al., 1979). When used as a 
diagnostic test, the HC induces hyperglycaemia for only a short period (2 - 3 h). To 
our knowledge, the effects of prolonging this technique on glucose metabolism and 
insulin secretion have not been investigated in horses. 
 
Although the HC involves varying the infusion rate to clamp blood glucose 
levels (the opposite approach to the one employed here) target blood glucose 
concentrations were comparable. Modification of the HC (i.e. to use fixed glucose 
infusion rates in the assessment of insulin secretion rates in humans) has been 
successful, with comparable results found between the two techniques (Kelley et al., 
2010). Thus, calculation of the approximate insulin sensitivity of the treated horses 
was possible using steady state blood glucose concentrations (12.5 ± 1.1 mmol/L), 
providing further data in this scant field of knowledge.  
 
The M value in the current study (0.039 ± 0.0012 mmol/kg/min) was higher 
than reported previously (Rijnen and van der Kolk, 2003) in Warmblood horses 
(0.011 ± 0.0045), and while it indicates a higher rate of metabolism of glucose (and 
sensitivity to insulin), is probably associated with the higher glucose infusion rate 
used in the current study (~270 mL/h vs. ~120 mL/h). However, the M-to-I ratio was 
similar in the two studies (0.017 ± 0.016 vs. 0.014 ± 0.002).  
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The M-to-I ratio calculated during a HC is an indicator of tissue sensitivity to 
endogenous (equine) insulin, in contrast to the EHC where the M-to-I ratio is a 
measure of tissue sensitivity to exogenously administered (human) insulin. The high 
serum insulin concentrations in the EHC also result in lower (100-fold) measures of 
insulin sensitivity due to the fact that increasing concentrations of insulin do not 
stimulate increased glucose metabolism but nevertheless do decrease the M-to-I ratio 
(DeFronzo et al., 1979). Thus, whereas the M values obtained from the two 
techniques are directly comparable, the M-to-I ratios are not (DeFronzo et al., 1979).  
 
A study examining the effects of a prolonged glucose infusion on healthy 
humans found that hyperglycaemia (12.6 mmol/L) over 68 h resulted in reduced 
insulin secretion, decreased insulin clearance and reduced insulin-stimulated glucose 
uptake (Boden et al., 1996). This glucose desensitisation was compensated for (in part) 
by a decrease in the clearance rate of insulin from the body. Whether a reduction in 
insulin secretion and clearance occurred in the horses in the current study is unknown, 
and the use of a variable glucose infusion rate would reveal whether decreasing 
amounts of glucose would be required to maintain hyperglycaemia.  
 
The infrequency with which horses develop hyperglycaemia may suggest that 
the equine pancreatic response to glucose is different to other species and is worthy of 
investigation. If insulin secretion remains at persistently high levels in horses in 
response to glucose intake, this may have implications for the pathogenesis of 
hyperinsulinaemic laminitis. However, the steadily increasing degree of glycosuria 
seen in our horses throughout the study supports the possibility that glucose 
desensitisation of peripheral tissues developed during the study. This finding may 
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suggest that horses are not able to continuously metabolise large amounts of glucose 
and that desensitisation occurs secondary to down-regulation or failure of glucose 
transporters.  
 
Lamellar histopathological lesions observed in the present study were similar 
to those seen in horses with EHC-induced laminitis (de Laat et al., 2011), although 
less severe, and included increased evidence of apoptosis, mitosis and elongation and 
narrowing of the SELs. Variations in the length and shape of PELs and SELs can be 
normal (Kawasako et al., 2009), however lamellar pathology seen in our study 
differed considerably to control horses. The lesions more closely resembled those 
seen during the developmental stages of an EHC (M.A. de Laat., unpublished data) 
and this may suggest that lamellar pathology could have progressed had the 
hyperinsulinaemia persisted beyond 48 h. Temporal studies on the effect of mild-to-
moderate hyperinsulinaemia on lamellar tissue are required. 
  
Conclusions 
The results of the current study demonstrate that a prolonged (48 h) glucose 
infusion induces moderate hyperinsulinaemia and subclinical lamellar pathology in 
insulin-sensitive horses. Although hyperglycaemia and glucose toxicity may be 
involved in the pathogenesis of endocrinopathic laminitis, it appears more likely that 
their primary role in disease pathogenesis is as a stimulus for insulin secretion. 
Moderate hyperinsulinaemia results in the development of lamellar compromise 
within 48 h, suggesting that lamellar pathology is potentially widespread in the 
hyperinsulinaemic equine population. An appreciation of the threshold for insulin 
toxicity may be important in the prevention of laminitis and our results suggest that 
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this threshold may be at or below ~ 200 µIU/mL. Swift and decisive management of 
even mild to moderate hyperinsulinaemia is therefore warranted.  
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Tables 
 
Table 1: Standardbred horses (n = 7) were treated with either an electrolyte solution 
(C1 – C3) or a continuous glucose infusion (G1 - G4), at a rate of 0.68 mL/kg/h for 48 
h. Histological evidence of lamellar pathology was assessed in all four feet of each 
horse and each foot was graded on a scale of 0 to 3, to obtain a score out of 12. The 
number of mitotic figures and dermal polymorphonucleocytes (PMNs) in each high 
power (400x) field (hpf) were examined. Mean ± se serum insulin concentration was 
calculated for each horse. 
 
Subject Histological 
grade of lamellar 
pathology (/12) 
Feet 
affected 
Number of 
mitotic 
figures/hpf 
Number of 
PMNs/hpf in 
dermis 
Serum 
insulin 
(µIU/mL) 
 
C1 0 - 0 0 8.6 ± 0.6  
C2 0 - 0-1 0 9.1 ±1.0  
C3 0 - 0 0 12 ± 1.6  
G1 1 RF 0-2 > 5 182 ± 30  
G2 3 LF, RF 0-15 > 10 135 ± 11  
G3 2 LF, RF 0-5 0-1 287 ± 42  
G4 4 all 0-10 > 5 231 ± 23  
 
Key:  The grading scale for each foot is as follows: 0, negative; 1, secondary epidermal lamellar (SEL) lengthening and 
narrowing, nuclear disorientation, prominent nucleoli, loss of uniform basal cell architecture and apoptosis; 2, as above plus 
increased mitosis and dermal polymorphonucleocytes; 3, marked cellular and structural changes with basement membrane 
dysadhesion and loss. RF, right fore; LF, left fore.
 21 
Figures 
 
 
 
 
Figure 1: Urine glucose concentration (mmol/L) was measured semi-quantitatively in 
Standardbred horses treated with either an infusion of glucose (●, 50% dextrose, n = 4) 
or a balanced electrolyte solution (□, n = 3) at 0.68 mL/kg/h for 48 h. Mean ± se urine 
glucose concentration increased steadily over the 48 h period in the glucose treated 
horses while control horses did not develop glycosuria at any time. 
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Figure 2: Mean ± se blood glucose concentration (mmol/L) was measured during a 
prolonged (48 h) glucose (50% dextrose; 0.68 mL/kg/h) infusion (●) in Standardbred 
horses (n = 4). Control horses (n = 3) received a prolonged (48 h) infusion of a 
balanced electrolyte solution (□). Blood glucose concentration remained in the normal 
range for the control horses but increased (P < 0.05) in treated horses. Blood glucose 
concentration during the steady state period (inset) was used to calculate insulin 
sensitivity. 
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Figure 3: Mean ± se serum insulin concentration (µIU/mL) was measured in 
Standardbred horses treated with either a glucose (50% dextrose) infusion (n = 4) or a 
balanced electrolyte solution (n = 3) for 48 h. Serum insulin concentration increased 
(P < 0.05) in treated horses (●) during the infusion period, but remained normal in 
control horses (□). 
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Figure 4: Representative photomicrographs from Standardbred horses receiving either 
an electrolyte (a, c inset) or glucose (50% dextrose) infusion (b, c, d) for 48 h. Control 
horses exhibited normal lamellar architecture (a) with tightly adhered PAS-stained 
basement membrane (BM) continuing the full length of the secondary epidermal 
lamellae (SEL) to the primary epidermal lamellar (PEL) axis (black arrowheads in a). 
Histopathological lesions in treated horses included loss of PAS-stained BM at the 
base of the SEL adjacent to the PEL axis (black arrowhead in b), patchy loss of 
definition of BM staining (black arrow in b), lengthening of SELs (c) and more 
frequent mitotic figures (white arrowheads in d). Infiltration of polymorphonuclear 
leucocytes around the axial tips of the PELs was seen in forefoot sections (white 
arrows in d). Stain = haematoxylin and eosin (a, b) or periodic acid Schiff (c, d). 
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Figure 5: Mean ± se length (µm) of ten secondary epidermal lamellae (SELs) was 
measured in the axial (SELLT) and abaxial (SELLB) halves of eight primary 
epidermal lamellae (PEL) from both forefeet of horses treated with either an infusion 
of glucose (█; 50% dextrose, n = 4) or an electrolyte solution (▒; n = 3) at 0.68 
mL/kg/h for 48 h. SELs of treated horses were longer (*, P < 0.05) abaxially and 
narrower (*, P < 0.05) at both locations when compared to the control group. 
